We are live on
!
Find out more
VanEck Associates Portfolio holdings
AUM
$133B
1-Year Est. Return
72.99%
This Fund
S&P 500
This Quarter
Est. Return
+10.34%
1 Year Est. Return
+72.99%
3 Year Est. Return
+157.94%
5 Year Est. Return
+206.35%
10 Year Est. Return
+770.56%
AUM
$43.2B
AUM Growth
+$3.45B
(+8.7%)
Cap. Flow
-$28.2M
Cap. Flow
% of AUM
-0.07%
Top 10 Holdings %
Top 10 Hldgs %
24.56%
Holding
1,434
New
145
Increased
810
Reduced
388
Closed
61
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Newmont
NEM
|
+$128M |
| 2 |
Mercado Libre
MELI
|
+$109M |
| 3 |
Veeva Systems
VEEV
|
+$106M |
| 4 |
Walt Disney
DIS
|
+$101M |
| 5 |
B
Barrick Mining
B
|
+$97M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$315M |
| 2 |
TSMC
TSM
|
+$277M |
| 3 |
Pfizer
PFE
|
+$123M |
| 4 |
SLB Ltd
SLB
|
+$115M |
| 5 |
Thermo Fisher Scientific
TMO
|
+$108M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Materials | 36.19% |
| 2 | Technology | 25.54% |
| 3 | Energy | 6.85% |
| 4 | Healthcare | 6.52% |
| 5 | Industrials | 3.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
BlackRock TCP Capital
TCPC
$279M
| $12.7M | 0.03% |
938,475
+67,718
| +8% | +$940K |
|
327
Guardant Health
GH
$21.8B
| $12.7M | 0.03% |
126,517
-5,173
| -4% | -$535K |
|
328
PepsiCo
PEP
$190B
| $12.6M | 0.03% |
72,643
+42,863
| +144% | +$7M |
|
329
BioMarin Pharmaceuticals
BMRN
$11.6B
| $12.6M | 0.03% |
142,808
-6,167
| -4% | -$509K |
|
330
Blackstone
BX
$104B
| $12.6M | 0.03% |
+97,487
| New | +$13M |
|
331
MidCap Financial Investment
MFIC
$797M
| $12.6M | 0.03% |
982,997
+70,831
| +8% | +$930K |
|
332
VanEck IG Floating Rate ETF
FLTR
$2.97B
| $12.5M | 0.03% |
495,100
| – | – |
|
333
Nuveen Municipal Credit Income Fund
NZF
$2.41B
| $12.5M | 0.03% |
730,950
+56,039
| +8% | +$948K |
|
|
PLL
334
DELISTED
Piedmont Lithium
PLL
| $12.4M | 0.03% |
236,404
-3,748
| -2% | -$219K |
|
335
Edwards Lifesciences
EW
$50.7B
| $12.4M | 0.03% |
95,340
+16,084
| +20% | +$1.88M |
|
336
VEON
VEON
$3.73B
| $12.3M | 0.03% |
287,067
+5,296
| +2% | +$258K |
|
337
Sun Communities
SUI
$15.2B
| $12.1M | 0.03% |
57,842
+15,290
| +36% | +$3.01M |
|
338
XPeng
XPEV
$11.9B
| $12.1M | 0.03% |
239,987
-3,119
| -1% | -$141K |
|
|
AESC
339
DELISTED
The AES Corporation
AESC
| $12M | 0.03% |
124,979
+5,343
| +4% | +$524K |
|
340
Healthpeak Properties
DOC
$15.1B
| $12M | 0.03% |
332,284
+85,110
| +34% | +$2.94M |
|
341
Bain Capital Specialty
BCSF
$815M
| $12M | 0.03% |
786,846
+115,350
| +17% | +$1.77M |
|
342
Monolithic Power Systems
MPWR
$64.7B
| $11.8M | 0.03% |
23,942
+19,791
| +477% | +$10.2M |
|
343
Bausch Health
BHC
$2.46B
| $11.7M | 0.03% |
424,766
+82,819
| +24% | +$2.22M |
|
|
MFA
344
MFA Financial
MFA
$935M
| $11.6M | 0.03% |
637,974
-29,409
| -4% | -$535K |
|
345
lululemon athletica
LULU
$13.8B
| $11.6M | 0.03% |
29,629
-1,472
| -5% | -$629K |
|
|
NIMC
346
DELISTED
NiSource Inc. Series A Corporate Units
NIMC
| $11.6M | 0.03% |
103,351
+4,419
| +4% | +$475K |
|
347
Ventas
VTR
$47.6B
| $11.5M | 0.03% |
225,699
+58,547
| +35% | +$3.06M |
|
348
AT&T
T
$160B
| $11.4M | 0.03% |
613,319
+86,813
| +16% | +$1.62M |
|
|
349
Thermo Fisher Scientific
TMO
$213B
| $11.4M | 0.03% |
17,017
-172,193
| -91% | -$108M |
|
350
Air Products & Chemicals
APD
$64.7B
| $11.3M | 0.03% |
37,290
+12,870
| +53% | +$3.78M |
|
Similar funds
VanEck Associates's Q4 2021 Portfolio in Review
As of Q4 2021, VanEck Associates held 1,434 positions worth $43.2B, up 8.7% from $39.8B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
VanEck Associates's Q4 2021 filing shows 145 new, 810 increased, 388 reduced and 61 closed positions. Its largest new stake was Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A: 47,930 shares worth $99.5M. The largest sale was NVIDIA, an estimated $315M.
By sector, the portfolio is most concentrated in Materials at 36% of assets, down from 36% a quarter earlier, followed by Technology and Energy.
- VanEck Associates's largest Q4 2021 buy was Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A: 47,930 shares worth $99.5M.
- VanEck Associates added most to Newmont in Q4 2021, an estimated $128M increase.
- VanEck Associates's biggest Q4 2021 reduction was NVIDIA, cutting an estimated $315M.
- VanEck Associates fully exited CIMAREX ENERGY CO in Q4 2021, selling an estimated $69.5M.
- VanEck Associates's ten largest holdings make up 25% of its $43.2B portfolio in Q4 2021.
- VanEck Associates opened 145 new positions and closed 61 in Q4 2021.
- VanEck Associates's portfolio value rose 8.7% quarter-over-quarter to $43.2B.
Based on VanEck Associates's 13F filing for Q4 2021, filed 26 Jan 2022.